Mark Van Allen, M.B.A.

Global Managing Director, Morgan Pacific Company, LLC

Mark Van Allen is currently serving as Chief Operating Officer of Provascor Pharmaceuticals, Inc., a University of Connecticut spin-out addressing late stage heart failure. Prior to this work, Mr. Van Allen was the President of the UConn Ventures, Inc. for 13 years. He has also held financial and operating positions in early stage investor-owned partnerships and companies. Mr. Van Allen is also the Managing Director of Morgan Pacific Company, LLC, a firm involved in technology transfer, investment and business development in Asia, Eastern Europe and the US. Earlier, he worked for Donaldson, Lufkin & Jenrette and Rotan Mosle, Inc., two full-service investment banking houses in New York. He was part of the initial team charged with the development of Science Park (a Yale-initiated business incubator) in New Haven and also developed and served as President of the Bridgeport Innovation Center (a for-profit business incubator) for eight years. He has served as Chairman and President of the Connecticut Venture Group. Mark received a B.A. Degree, Human Biology, and an MBA Degree, Finance— both from Stanford University, Stanford, California.